1. Walsh R, Locarnini S. Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J. 2012;53(5):875-85. doi: 10.3349/ymj.2012.53.5.875. [
DOI:10.3349/ymj.2012.53.5.875]
2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(S5). doi: 10.1002/hep.22898. [
DOI:10.1002/hep.22898]
3. Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol. 2005; 16(2): 65-72. PMCID: PMC2095015. [
DOI:10.1155/2005/450574]
4. Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum: disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterol. 1990; 99(4): 1113-9. [
DOI:10.1016/0016-5085(90)90632-B]
5. Yoo BC, Park J-W, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2003; 38(1): 98-103. [
DOI:10.1016/S0168-8278(02)00349-5]
6. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001; 135(9): 759-68. [
DOI:10.7326/0003-4819-135-9-200111060-00006]
7. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990; 64(3): 1298-303. PMID:2304145.2017; 10(1): 39-43.
8. Brunetto M. Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol. 1989; 21: 151-4.
9. Carman W, Hadziyannis S, McGarvey M, Jacyna M, Karayiannis P, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. The Lancet. 1989; 334(8663): 588-91. [
DOI:10.1016/S0140-6736(89)90713-7]
10. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen—negative chronic hepatitis B. Hepatology. 2001; 34(4): 617-24. [
DOI:10.1053/jhep.2001.27834]
11. Naoumov NV, Schneider R, Grötzinger T, Jung MC, Miska S, Pape GR, et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterol. 1992; 102(2): 538-43. [
DOI:10.1016/0016-5085(92)90101-4]
12. Sali S, Sharafi H, Alavian SH, Alavian SM, Etesam F, Salimi S, et al. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state? Diagnostic microbiology and infectious disease. 2015; 82(2): 114-9. doi: 10.1016/j.diagmicrobio.2015.02.005. [
DOI:10.1016/j.diagmicrobio.2015.02.005]
13. Esmaeelzadeh A, Saadatnia H, Memar B, Amirmajdi EM, Ganji A, Goshayeshi L, et al. Evaluation of serum HBV viral load, transaminases and histological features in chronic HBeAg-negative hepatitis B patients. Gastroenterology and Hepatology from bed to bench.